Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | CURV | Common Stock | 205K | Jun 6, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | CURV | Option to purchase shares | Jun 6, 2024 | Common Stock | 214K | $5.99 | Direct | F2 | ||||||
holding | CURV | Option to purchase shares | Jun 6, 2024 | Common Stock | 90.2K | $3.23 | Direct | F3 | ||||||
holding | CURV | Option to purchase shares | Jun 6, 2024 | Common Stock | 63K | $4.51 | Direct | F4 |
Id | Content |
---|---|
F1 | Represents (1) 31,735 common stock shares outstanding , (2) 93,907 restricted stock units (RSUs) that remain unvested from an initial August 22, 2022 grant of 125,209 RSUs which started vesting on August 22, 2023, in an installment substantially equal to 25% of the grant, and will vest on August 22, 2024, August 22, 2025 and August 22, 2026, respectively; (3) 40,635 RSUs that remain unvested from a grant of 54,180 RSUs which started vesting on March 27, 2024, in an installment substantially equal to 25% of the grant, and will vest on March 27, 2025, March 27, 2026 and March 27, 2027, respectively; and (4) 38,803 RSUs, which will vest annually in substantially equal 25% installments on April 2, 2025, April 2, 2026, April 2, 2027 and April 2, 2028, subject to the reporting person's continued employment through the applicable vesting date. |
F2 | Represents options to purchase shares that started vesting on August 22, 2023 and become exercisable in substantially equal 25% installments on August 22, 2023, August 22, 2024, August 22, 2025 and August 22, 2026, respectively, subject to the reporting person's continued employment through the applicable vesting date. |
F3 | Represents options to purchase shares that started vesting on March 27, 2024 and become exercisable in substantially equal 25% installments on March 27, 2024, March 27, 2025, March 27, 2026 and March 27, 2027, respectively, subject to the reporting person's continued employment through the applicable vesting date. |
F4 | Represents options to purchase shares that will start vesting on April 2, 2025 and become exercisable in substantially equal 25% installments on April 2, 2025, April 2, 2026, April 2, 2027 and April 2, 2028, respectively, subject to the reporting person's continued employment through the applicable vesting date. |
Exhibit 24: Power of Attorney